Exelis Inc.


Monday Morning’s Pre-Market Insights: Adamis Pharmaceuticals Corp (ADMP), Exelixis, Inc. (EXEL), Juno Therapeutics Inc (JUNO), and Ariad Pharmaceuticals, Inc. (ARIA)

Adamis Pharmaceuticals Corp (NASDAQ:ADMP) is plummeting nearly 50% down to $4.55 after the FDA rejected the company’s New Drug Application for the second …

Tuesday Morning’s Market Insights: GoPro Inc (GPRO), Exelis, Inc. (EXEL), Can Fite Biopharma Ltd (ADR) (CANF), First Solar, Inc. (FSLR)

GoPro Inc (NASDAQ:GPRO) is up 2.73% in pre-market trading as tech fans prepare for the CES 2016 conference in Las Vegas, set to …

Company Update (NASDAQ:EXEL): Exelixis, Inc. Completes Submission of New Drug Application for Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma

Exelixis, Inc. (NASDAQ:EXEL) announced that it has completed the submission of its rolling New Drug Application (NDA) with the U.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts